Literature DB >> 23223913

[Risk of non-melanoma skin cancer under TNF inhibition. New aspects from the British Biologics Register].

A Zink1.   

Abstract

Entities:  

Year:  2013        PMID： 23223913     DOI： 10.1007/s00393-012-1092-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  2 in total

1.  Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2007-09

2.  Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.

Authors:  Lene Dreyer; Lene Mellemkjær; Anne Rødgaard Andersen; Philip Bennett; Uta Engling Poulsen; Torkell Juulsgaard Ellingsen; Torben Høiland Hansen; Dorte Vendelbo Jensen; Louise Linde; Hanne Merete Lindegaard; Anne Gitte Rasmussen Loft; Henrik Nordin; Emina Omerovic; Claus Rasmussen; Annette Schlemmer; Ulrik Tarp; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2012-09-03       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.